Role of cytochrome P450 metabolites of arachidonic acid in hypertension
about
Cocoa, chocolate, and cardiovascular diseaseCYP4 enzymes as potential drug targets: focus on enzyme multiplicity, inducers and inhibitors, and therapeutic modulation of 20-hydroxyeicosatetraenoic acid (20-HETE) synthase and fatty acid ω-hydroxylase activitiesPharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammationInhibition of soluble epoxide hydrolase enhances the anti-inflammatory effects of aspirin and 5-lipoxygenase activation protein inhibitor in a murine modelArachidonate Epoxygenase / Epoxide HydrolaseAltered inflammatory responses to Citrobacter rodentium infection, but not bacterial lipopolysaccharide, in mice lacking the Cyp4a10 or Cyp4a14 genes.20-Hydroxyeicosatetraenoic acid synthesis is increased in human neutrophils and platelets by angiotensin II and endothelin-1.Impact of vascular thromboxane prostanoid receptor activation on hemostasis, thrombosis, oxidative stress, and inflammation.Chronic activation of AMP-activated protein kinase prevents 20-hydroxyeicosatetraenoic acid-induced endothelial dysfunction.20-HETE and EETs in diabetic nephropathy: a novel mechanistic pathwayP450 in the angiogenesis affair: the unusual suspect.Ethnic differences in the prevalence of polymorphisms in CYP7A1, CYP7B1 AND CYP27A1 enzymes involved in cholesterol metabolism.Dietary ω3 fatty acid exerts anti-allergic effect through the conversion to 17,18-epoxyeicosatetraenoic acid in the gut.Hypertension and oxidative stress.Animal and human tissue Na,K-ATPase in normal and insulin-resistant states: regulation, behaviour and interpretative hypothesis on NEFA effects.Pathogenesis of essential hypertension: historical paradigms and modern insights.Expression of CYP4F2 in human liver and kidney: assessment using targeted peptide antibodies.The molecular sources of reactive oxygen species in hypertension.Calcium-activated potassium channels and endothelial dysfunction: therapeutic options?Oxidized fatty acid analysis by charge-switch derivatization, selected reaction monitoring, and accurate mass quantitation.Sorafenib has soluble epoxide hydrolase inhibitory activity, which contributes to its effect profile in vivo.Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE.Clinical Implications of 20-Hydroxyeicosatetraenoic Acid in the Kidney, Liver, Lung and Brain: An Emerging Therapeutic TargetReno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease.Modulation of cardiac cytochrome P450 in patients with heart failure.Modulation of arachidonic Acid metabolism in the rat kidney by sulforaphane: implications for regulation of blood pressure.Gene expression study of phase I and II metabolizing enzymes in RPTEC/TERT1 cell line: application in in vitro nephrotoxicity prediction.A Genetic Response Score for Hydrochlorothiazide Use: Insights From Genomics and Metabolomics Integration.Convenient syntheses of [20,20,20-H(3)]-arachidonic acid and [20,20-H(2)]-20-hydroxyeicosatetraenoic acidMolecular mechanisms of cold-induced CYP1A activation in rat liver microsomes.Dietary Doses of Sulforaphane Affect Hepatic Drug Metabolizing Enzymes in Spontaneously Hypertensive Rats.Cytochrome P450 metabolites of arachidonic acid are elevated in stroke patients compared with healthy controlsTranscriptomic profile analysis of brain microvascular pericytes in spontaneously hypertensive rats by RNA-Seq
P2860
Q24654705-D2AC2F9F-DBA1-43DF-8979-ABBDDC0132E6Q28290987-B128157F-34B5-43A5-AA3E-153D356294A5Q28389323-0A0A96A4-08A7-4412-B8DF-9C29012DD346Q28396881-B0A35E90-30B2-42C9-9046-B6EA24ED7964Q30230898-9A013A1B-6146-48FA-8F7E-F395E9E894F3Q33671358-0EDB8179-8572-4A0E-922A-C42379E8AD41Q34159332-3D609CE8-D4AE-4FE2-BCB7-FBCD7DECA01CQ34389439-ACDA4B75-2CA5-4FF5-A1F5-A1799F439AE9Q34918014-F9CA77D1-3903-4C67-90AF-E9083EB6BC74Q34924935-A905EA53-D878-4D6A-8987-F2D3A866881FQ35083598-1C6A982A-DF72-4B78-9922-E495B1160B2CQ35228921-066218B1-50D9-409C-BAFB-5AB8BBEC4663Q35727514-9E555C8D-5096-41BF-AFDB-89F058AB6DC8Q36572712-5992BF73-3E49-4B40-9DBF-52C7688DC900Q36795874-EF52B513-7952-45F6-8E57-DC0E5B87D51DQ37094953-E007CACA-21EC-4398-BDEA-F9D0BF015F75Q37109910-D1EDE0A0-2D96-416E-8D4B-6D9C794C0AA5Q37196365-E255A056-E9F6-4868-AB75-046935410FE3Q37230725-6664C56D-7BAD-40D6-AFA2-5017186F9DA5Q37296539-087DC698-F29C-43CC-A8AA-52DD86CFAE4AQ37308544-E49019D8-5BDA-4ED8-B0E7-87649434D6F3Q37417272-E3294A84-86CF-4F28-9740-FF0B062616B3Q37731230-09B0A66D-AD4F-41A8-B469-2B9BB43FCE5DQ37960812-036FC786-02DA-42C4-A116-6F2829BE9E44Q38175461-A5C77AD6-A747-4D1D-80D0-D2D67AD51CCDQ38480014-2DB805B8-A5A4-4F80-9EE1-D2B750A3453DQ38746906-00508504-ACFA-4571-B54A-61C4215F5835Q39628839-612D8BC3-0031-4842-AB64-9D8D3978F55AQ41915303-BD741D83-1A12-4B10-89B3-D38167B87E9BQ42742344-1AEC683A-EF46-454C-82DC-1B65363F472DQ53837510-BAFA2167-CC52-4D36-B785-C70297FFD7D0Q57313058-88DAB763-0DB1-4034-AD1F-6DBFF19B933EQ58775959-19E1FEF5-CC11-4AD4-B1EC-808F62A9781B
P2860
Role of cytochrome P450 metabolites of arachidonic acid in hypertension
description
2004 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունիսին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2004
@ast
scientific journal article
@en
vedecký článok (publikovaný 2004/06/01)
@sk
vědecký článek publikovaný v roce 2004
@cs
wetenschappelijk artikel (gepubliceerd op 2004/06/01)
@nl
наукова стаття, опублікована в червні 2004
@uk
مقالة علمية (نشرت في يونيو 2004)
@ar
name
Role of cytochrome P450 metabolites of arachidonic acid in hypertension
@ast
Role of cytochrome P450 metabolites of arachidonic acid in hypertension
@en
Role of cytochrome P450 metabolites of arachidonic acid in hypertension
@nl
type
label
Role of cytochrome P450 metabolites of arachidonic acid in hypertension
@ast
Role of cytochrome P450 metabolites of arachidonic acid in hypertension
@en
Role of cytochrome P450 metabolites of arachidonic acid in hypertension
@nl
prefLabel
Role of cytochrome P450 metabolites of arachidonic acid in hypertension
@ast
Role of cytochrome P450 metabolites of arachidonic acid in hypertension
@en
Role of cytochrome P450 metabolites of arachidonic acid in hypertension
@nl
P356
P1476
Role of cytochrome P450 metabolites of arachidonic acid in hypertension
@en
P2093
R. J. Roman
P304
P356
10.2174/1389200043335603
P407
P577
2004-06-01T00:00:00Z